Angiotensin II Type 1 Receptor Antagonist Attenuates Lacrimal Gland, Lung, and Liver Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yaguchi, Saori ^a   Ogawa, Yoko ^a   Shimmura, Shigeto ^a   Kawakita, Tetsuya ^a   Hatou, Shin ^a   Satofuka, Shingo ^a   Nakamura, Shigeru ^a   Imada, Toshihiro ^a   Miyashita, Hideyuki ^a   Yoshida, Satoru ^a   Yaguchi, Tomonori ^a   Ozawa, Yoko ^a   Mori, Takehiko ^a   Okamoto, Shinichiro ^a   Kawakami, Yutaka ^a   Ishida, Susumu ^b   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; MESSENGER RNA; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LACRIMAL GLAND DISEASE; LACRIMAL GLAND FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENETICS; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; LACRIMAL APPARATUS; LIVER; LUNG; MALE; PATHOLOGY;

MURINAE; MUS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; GENE EXPRESSION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMIDAZOLES; LACRIMAL APPARATUS; LIVER; LUNG; MALE; MICE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; VALINE; VALSARTAN;

EID: 84878795830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064724     Document Type: Article

References (51)

1. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, et al. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11: 945-956.
2. Lee SJ, (2005) New approaches for preventing and treating chronic graft-versus-host disease. Blood 105: 4200-4206.
3. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, et al. (1999) Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 83: 1125-1130.
4. Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, et al. (2001) A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 42: 111-119.
5. Cooke KR, Yanik GA (2009) Thomas' Hematopoietic Cell transplantation Stem Cell Transplantation. Fourth edition. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Lung injury following hematopoietic cell transplantation. Oxford UK, West Sussex UK, NJ USA: Wiley-Blackwell. 1456-1472.
6. Strasser SI, McDonald GB (2009) Thomas' Hematopoietic Cell transplantation Stem Cell Transplantation. Fourth edition. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Gastrointestinal and Hepatic complications. Oxford UK, West Sussex UK, NJ USA: Wiley-Blackwell. 1434-1455.
7. McCormick LL, Zhang Y, Tootell E, Gilliam AC, (1999) Anti-TGF-β treatment prevent skin and lung fibrosis in murine sclerodermatous graft-versus- host disease: a model for human scleroderma. J Immunol 163: 5693-5699.
8. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC, (2002) Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 168: 3088-3098.
9. Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, et al. (2004) Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104: 1565-1573.
10. Li J, Helm K, Howell CD, (1996) Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease. Transplantation 62: 1621-1628.
11. Nonomura A, Kono N, Minato H, Nakanuma Y, (1998) Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice. Pathol Int 48: 421-427.
12. Peach MJ, (1977) Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370.
13. Reid IA, Morris BJ, Ganong WF, (1978) The renin-angiotensin system. Annu Rev Physiol 40: 377-410.
14. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, et al. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251.
15. Paul M, Poyan Mehr A, Kreutz R, (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803.
16. Yaguchi S, Ogawa Y, Shimmura S, Hatou S, Nakamura S, et al. (2012) Presence and physiologic function of the Renin-Angiotensin system in mouse lacrimal gland. Invest Ophthalmol Vis Sci 53: 5416-5425.
17. Bullock GR, Steyaert I, Bilbe G, Carey RM, Kips J, et al. (2001) Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol 115: 117-124.
18. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, et al. (2002) Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-1676.
19. Munshi MK, Uddin MN, Glaser SS, (2011) The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med (Maywood) 236: 557-566.
20. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, et al. (2001) Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325.
21. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, et al. (2001) Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34: 745-750.
22. Chou HC, Lang YD, Wang LF, Wu TY, Hsieh YF, et al. (2012) Angiotensin II type 1 receptor antagonist attenuates lung fibrosis in hyperoxia-exposed newborn rats. J Pharmacol Exp Ther 340: 169-175.
23. Kurihara T, Ozawa Y, Shinoda K, Nagai N, Inoue M, et al. (2006) Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci 47: 5545-5552.
24. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, et al. (2006) Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol 26: 2252-2259.
25. Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, et al. (2007) Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci 48: 4342-4350.
26. Hopwood J (1996) Theory and practice of Histological Techniques. Fourth edition. In: Bancroft JD, Stevens A, editors. Fixation and fixative. Edinburgh: Churchill-Livingstone. 23-46.
27. Anderson G, Gordon K (1996) Theory and practice of Histological Techniques. Fourth edition. In: Bancroft JD, Stevens A, editors. Tissue processing, microtomy and paraffin sections. Edinburgh: Churchill-Livingstone. 47-68.
28. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, et al. (1998) The En Vision™+system: a new immunohistochemical method for diagnostics and research: critical comparison with the APAAP, Chem Mate™, CSA, LABC, and SABC. J Clin Pathol 51: 506-511.
29. Ogawa Y, Razzaque MS, Kameyama K, Hasegawa G, Shimmura S, et al. (2007) Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD. Invest Ophthalmol Vis Sci 48: 1079-1086.
30. Brack AS, Conboy MJ, Roy S, Lee M, Kou CJ, et al. (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807-810.
31. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
32. Rosenkranz S, (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63: 423-432.
33. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, et al. (2003) NADPH oxidase signaling transduces angiotensin II in hepatic stellate cells and is a critical in hepatic fibrosis. J Clin Invest 112: 1383-1394.
34. Rüster C, Wolf G, (2011) Angiotensin II as a Morphogenic Cytokine stimulating renal Fibrogenesis. J Am Soc Nephrol 22: 1189-1199.
35. Chan YC, Leung PS, (2011) The Renin-angiotensin system and reactive oxygen species: implications in pancreatitis. Antioxid Redox Signal 15: 2743-2755.
36. Yahata Y, Shirakata Y, Tokumaru S, Yang L, Dai X, et al. (2006) A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem 281: 13209-13216.
37. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, et al. (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286: 156-164.
38. Marshall RP, McAnulty RJ, Laurent GJ, (2000) Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161: 1999-2004.
39. Kagami S, Border WA, Miller DE, Noble NA, (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437.
40. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, et al. (2000) Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101: 1130-1137.
41. Omary MB, Lugea A, Lowe AW, Pandol SJ, (2007) The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 117: 50-59.
42. Blazar BR, Murphy WJ, Abedi M, (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12: 443-458.
43. Luft FC, Dechend R, Müller DN, (2012) Immune mechanisms in angiotensin II-induced target-organ damage. Ann Med 44(Suppl 1): S49-54.
44. Sata M, Fukuda D, (2011) Chronic inflammation and atherosclerosis: A critical role for renin angiotensin system that is activated by life-style related diseases. Inflamm Regen 31: 245-255.
45. Cole BK, Keller SR, Wu R, Carter JD, Nadler JL, et al. (2010) Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension 55: 715-721.
46. Rasini E, Cosentino M, Marino F, Legnaro M, Ferrari M, et al. (2006) Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept 134: 69-74.
47. Lang YD, Hung CL, Wu TY, Wang LF, Chen CM, (2010) The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts. Free Radic Biol Med 49: 88-95.
48. Papp M, Li X, Zhuang J, Wang R, Uhal BD, (2002) Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol 282: 713-718.
49. Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, et al. (2003) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125: 117-125.
50. Nagata K, (1998) Expression and function of heat shock protein 47: a collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biol 16: 379-386.
51. Taguchi T, Nazneen A, Al-Shihri AA, Turkistani KA, Razzaque MS, (2011) Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells. Acta Histochem Cytochem 44: 35-41.